PMID: 8960109Oct 1, 1996Paper

Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression

Leukemia Research
Sophia KhaldoyanidiM Zöller

Abstract

In a variety of human tumors, including high grade Non-Hodgkin's lymphoma (hgNHL), a linkage between expression of CD44 variant isoforms (CD44v) and tumor progression has been described. In search of an easily accessible diagnostic parameter, expression of CD44 standard (CD44s) and CD44 variant isoforms (exons v5, v6, v7 and v10) in peripheral blood lymphocytes (PBLs) of patients with hematological malignancies was evaluated by fluorescence activated cell scanning. The analysis of 30 blood samples of healthy donors and patients with non-malignant diseases and of 183 blood samples of patients with malignant hematological disorders revealed that only in patients with malignant disorders did a measurable proportion of PBLs express CD44 variant isoforms, mostly exons v5, v6, v7 and, less frequently, exon v10. Elevated levels of CD44v expression were noted in PBLs of patients with acute and chronic myeloid leukemia (AML: 16%, CML: 25%), Hodgkin's disease (HD: 17%), multiple myeloma (MM: 22%), polycythemia vera (PV: 33%), acute lymphoid leukemia (ALL: 23%) and, most frequently, in PBLs of patients with non-Hodgkin's lymphoma (NHL:54%). CD44v expression was not restricted to the malignant phenotype, but instead was also noted in T cel...Continue Reading

References

Feb 1, 1992·European Journal of Immunology·A PierresD Olive
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G R ScreatonJ I Bell
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A SethP S Nagarkatti
Oct 1, 1991·The Journal of Experimental Medicine·M S SyI Stamenkovic
Sep 1, 1991·Immunobiology·A ColladoF Garrido
May 1, 1991·The Journal of Clinical Investigation·S JalkanenP Klemi
Feb 1, 1990·The Journal of Experimental Medicine·K MiyakeP W Kincade
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R L IdzerdaT St John
Feb 6, 1988·Lancet·A G StansfeldO Mioduszewska
Jan 1, 1994·The Journal of Cell Biology·C R MackayU Günthert
Jan 1, 1994·Critical Reviews in Oncogenesis·K K Tanabe, H Saya
Jul 1, 1995·Nature Medicine·D L Cooper, G J Dougherty
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K WirthM Zöller
Jul 1, 1993·Journal of Leukocyte Biology·F Lund-Johansen, L W Terstappen
Aug 28, 1993·Lancet·S B FoxJ Fawcett
Feb 1, 1993·The Journal of Experimental Medicine·S SeiterM Zöller
Mar 11, 1993·Nucleic Acids Research·C TölgH Ponta
Jun 1, 1996·Virchows Archiv : an International Journal of Pathology·S SeiterM Zöller

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.